Pseudomonas cepacia susceptibility to sulbactam
Open Access
- 1 April 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (4) , 583-584
- https://doi.org/10.1128/aac.33.4.583
Abstract
For 25 of 32 Pseudomonas cepacia isolates, predominantly from sputum of adult patients, agar dilution MICs of sulbactam were 2.5 micrograms/ml, and for only one was the MIC more than 80 micrograms/ml. Susceptibility was reliably predicted by response to a commercial sulbactam-ampicillin disk.This publication has 7 references indexed in Scilit:
- Sulbactam/Ampicillin: In Vitro Spectrum, Potency, and Activity in Models of Acute InfectionClinical Infectious Diseases, 1986
- Pseudomonas cepacia: Biology, mechanisms of virulence, epidemiologyThe Journal of Pediatrics, 1986
- Pseudomonas cepacia infection in cystic fibrosis: An emerging problemThe Journal of Pediatrics, 1984
- Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepaciaJournal of Antimicrobial Chemotherapy, 1983
- Subacute and acute endocarditis due to pseudomonas cepacia in heroin addictsThe American Journal of Medicine, 1975
- In Vitro Susceptibility of Pseudomonas cepacia and Pseudomonas maltophilia to Trimethoprim and Trimethoprim-SulfamethoxazoleAntimicrobial Agents and Chemotherapy, 1975
- Pseudomonas cepacia pneumoniaThe Lancet Healthy Longevity, 1973